BioCentury
ARTICLE | Company News

Introgen board of directors update

September 3, 2002 7:00 AM UTC

Introgen Therapeutics Inc. (INGN), Austin, Texas Business: Gene/Cell therapy, Cancer Resigned: Elise Wang, analyst at Salomon Smith Barney ...